REAL-WORLD ASSESSMENT OF CTDNA STATUS POST-NEOADJUVANT AND ADJUVANT THERAPY IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA UNDERGOING CURATIVE-INTENT RESECTION
HPB · 2026 · 28 · S19
DOI: 10.1016/j.hpb.2026.04.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2026. Verfasst von S. Logarajah und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Logarajah, S., Jomy, A., Aushev, V., Antonopoulos, A., Madhurapantula, R., Sharma, S., Subramaniam, S., Jurdi, A., Liu, M., & Jeyarajah, D. (2026). REAL-WORLD ASSESSMENT OF CTDNA STATUS POST-NEOADJUVANT AND ADJUVANT THERAPY IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA UNDERGOING CURATIVE-INTENT RESECTION. HPB, 28, S19. https://doi.org/10.1016/j.hpb.2026.04.032
Vancouver
Logarajah S, Jomy A, Aushev V, Antonopoulos A, Madhurapantula R, Sharma S, et al. REAL-WORLD ASSESSMENT OF CTDNA STATUS POST-NEOADJUVANT AND ADJUVANT THERAPY IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA UNDERGOING CURATIVE-INTENT RESECTION. HPB. 2026;28:S19. doi:10.1016/j.hpb.2026.04.032
BibTeX
@article{Logarajah2026,
author = {Logarajah, S. and Jomy, A. and Aushev, V. and Antonopoulos, A. and Madhurapantula, R.S. and Sharma, S. and Subramaniam, S. and Jurdi, A. and Liu, M.C. and Jeyarajah, D.R.},
title = {REAL-WORLD ASSESSMENT OF CTDNA STATUS POST-NEOADJUVANT AND ADJUVANT THERAPY IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA UNDERGOING CURATIVE-INTENT RESECTION},
journal = {HPB},
year = {2026},
volume = {28},
pages = {S19},
doi = {10.1016/j.hpb.2026.04.032}
}
EUVIMED